Abstract
Pancreatic ductal adenocarcinoma is the eighth most common cancer with the lowest overall 5-year relative survival rate of any tumor type today. Expression profiling using microarrays has been widely used to identify genes associated with pancreatic cancer development. To extract maximum value from the available gene expression data, we applied a meta-analysis to search for commonly differentially expressed genes in pancreatic ductal adenocarcinoma. We obtained data sets from four different gene expression studies on pancreatic cancer. We selected a consensus set of 2984 genes measured in all four studies and applied a meta-analysis approach to evaluate the combined data. Of the genes identified as differentially expressed, several were validated using RT–PCR and immunohistochemistry. Additionally, we used a class discovery algorithm to identify a gene expression signature. Our meta-analysis revealed that the pancreatic cancer gene expression data sets shared a significant number of up- and downregulated genes, independent of the technology used. This interstudy crossvalidation approach generated a set of 568 genes that were consistently and significantly dysregulated in pancreatic cancer. Of these, 364 (64.1%) were upregulated and 204 (35.9%) were downregulated in pancreatic cancer. Only 127 (22%) were described in the published individual analyses. Functional annotation of the genes revealed that genes presumably associated with the cell adhesion-mediated drug resistance pathway are frequently overexpressed in pancreatic cancer. Meta-analysis is an important tool for the identification and validation of differentially expressed genes. These could represent good candidates for novel diagnostic and therapeutic approaches to pancreatic cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R and Neoptolemos JP . (2004). Br. J. Surg., 91, 1410–1427.
Bubendorf L, Nocito A, Moch H and Sauter G . (2001). J. Pathol., 195, 72–79.
Collins R, Peto R, Gray R, Maynard A and Chalmers I . (1997). Non-random Reflections on Health Services Research. BMJ Publishing Group: London, pp. 197–230.
Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M, Terris B, Costello E, Neoptolemos JP and Lemoine NR . (2003). J. Pathol., 201, 63–74.
Damiano JS, Cress AE, Hazlehurst LA, Shtil AA and Dalton WS . (1999). Blood, 93, 1658–1667.
Ding XZ, Hennig R and Adrian TE . (2003). Mol. Cancer, 2, 10.
Eysenck HJ . (1995). Systematics Reviews Altman D and Chalmers I. (eds). BMJ Publishing Group: London, pp. 64–74.
Friess H, Ding J, Kleeff J, Fenkell L, Rosinski JA, Guweidhi A, Reidhaar-Olson JF, Korc M, Hammer J and Buchler MW . (2003). Cell. Mol. Life Sci., 60, 1180–1199.
Friess H, Ding J, Kleeff J, Liao Q, Berberat PO, Hammer J and Buchler MW . (2001). Ann. Surg., 234, 769–778.
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES . (1999). Science, 286, 531–537.
Grutzmann R, Foerder M, Alldinger I, Staub E, Brummendorf T, Ropcke S, Li X, Kristiansen G, Jesnowski R, Sipos B, Lohr M, Luttges J, Ockert D, Kloppel G, Saeger HD and Pilarsky C . (2003). Virchows Arch., 443, 508–517.
Grutzmann R, Luttges J, Sipos B, Ammerpohl O, Dobrowolski F, Alldinger I, Kersting S, Ockert D, Koch R, Kalthoff H, Schackert HK, Saeger HD, Kloppel G and Pilarsky C . (2004a). Br. J. Cancer, 90, 1053–1058.
Grutzmann R, Saeger HD, Luttges J, Schackert HK, Kalthoff H, Kloppel G and Pilarsky C . (2004b). Int. J. Colorectal Dis., 19, 401–413.
Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB and Von Hoff DD . (2002). Cancer Res., 62, 2890–2896.
Hazlehurst LA, Landowski TH and Dalton WS . (2003). Oncogene, 22, 7396–7402.
Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M and Hruban RH . (2003a). Cancer Res., 63, 8614–8622.
Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO and Goggins M . (2003b). Am. J. Pathol., 162, 1151–1162.
Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M and Hruban RH . (2002). Am. J. Pathol., 160, 1239–1249.
Ito H, Duxbury M, Benoit E, Clancy TE, Zinner MJ, Ashley SW and Whang EE . (2004). Cancer Res., 64, 7439–7446.
Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ . (2003). CA Cancer J. Clin., 53, 5–26.
Liotta L and Petricoin E . (2000). Nat. Rev. Genet., 1, 48–56.
Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, Misek DE and Hanash S . (2003). Cancer Res., 63, 2649–2657.
Luttges J, Schemm S, Vogel I, Hedderich J, Kremer B and Kloppel G . (2000). J. Pathol., 191, 154–161.
Luttges J, Zamboni G, Longnecker D and Kloppel G . (2001). Am. J. Surg. Pathol., 25, 942–948.
Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, Hirano S, Kondo S, Katoh H, Nakamura Y and Katagiri T . (2004). Oncogene, 23, 2385–2400.
Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM . (2004). Proc. Natl. Acad. Sci. USA, 101, 9309–9314.
Sager R . (1997). Proc. Natl. Acad. Sci. USA, 94, 952–955.
Storey JD and Tibshirani R . (2003a). Methods Mol. Biol., 224, 149–157.
Storey JD and Tibshirani R . (2003b). Proc. Natl. Acad. Sci. USA, 100, 9440–9445.
Sutton AJ, Abrams KR, Jones DR, Sheldon TA and Song F . (2000). Methods for Meta-analysis in Medical Research. Wiley: Chichester.
Tan ZJ, Hu XG, Cao GS and Tang Y . (2003). World J. Gastroenterol., 9, 818–823.
Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Lowenberg B and Delwel R . (2004). N. Engl. J. Med., 350, 1617–1628.
Whitehead A and Whitehead J . (1991). Stat. Med., 10, 1665–1677.
Acknowledgements
We thank Helmut Friess (Heidelberg, Germany) and Tatjana Crnogorac-Jurcevic (London, UK) for providing the original data set from their publications on request. We thank the authors of the other two studies on pancreatic cancer gene expression used in this meta-analysis for making their data publicly available. Moreover, we also thank K Dege for critical reading of the manuscript.
This study was supported by Deutsche Krebshilfe (70-2937-SaI).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Supplementary information
Rights and permissions
About this article
Cite this article
Grützmann, R., Boriss, H., Ammerpohl, O. et al. Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene 24, 5079–5088 (2005). https://doi.org/10.1038/sj.onc.1208696
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208696
Keywords
This article is cited by
-
Pancreatic Cancer: Genetic Conditions and Epigenetic Alterations
Journal of Gastrointestinal Surgery (2023)
-
Possible proteomic biomarkers for the detection of pancreatic cancer in oral fluids
Scientific Reports (2020)
-
Meta-Analysis Based on Nonconvex Regularization
Scientific Reports (2020)
-
Graph-theoretical comparison of normal and tumor networks in identifying BRCA genes
BMC Systems Biology (2017)
-
Transcriptome meta-analysis reveals a dysregulation in extra cellular matrix and cell junction associated gene signatures during Dengue virus infection
Scientific Reports (2016)